Original ArticleUnderdiagnosis of Pediatric Obesity and Underscreening for Fatty Liver Disease and Metabolic Syndrome by Pediatricians and Pediatric Subspecialists
Section snippets
Patient Population
The medical records of all patients age 2 to 18 years evaluated in 5 outpatient clinics at Stanford University (SU) and the University of California San Francisco (UCSF) between July 1, 2003 and September 30, 2003 were reviewed. These clinics were General Pediatrics (SU only), Pediatric Endocrinology (SU and UCSF), and Pediatric Gastroenterology (SU and UCSF). For the General Pediatrics clinic, only those visits for well-child care were included. Records that did not contain a documented height
Results
Table I displays selected characteristics of the visits studied; 715 visits (32%) involved children with a BMI% ≥ 85%, and 19% of all visits involved children with a BMI% of ≥ 95%. A higher percentage of General Pediatrics visits involved overweight children (41%) than Pediatric Endocrinology (38%) or Pediatric Gastroenterology (20%) visits. The likelihood of a diagnosis of overweight in all clinics for children of various BMI% is shown in Figure 1. Overall, children with BMI% 85% to 89% and
Discussion
Some previous studies have evaluated the diagnosis and management of obesity in adults,11, 12 and others have examined pediatricians' self-reported practices.8, 9 We report the results of the first study performed to directly assess the frequency with which general pediatricians, pediatric endocrinologists, and gastroenterologists at academic centers diagnose and manage obesity and obesity-related comorbidities.
This study highlights the fact that the diagnosis of overweight is not made during
References (13)
- et al.
Prevalence of abnormal serum aminotransferase values in overweight and obese adolescents
J Pediatr
(2000) - et al.
Prevalence and trends in overweight among US children and adolescents, 1999-2000
JAMA
(2002) Extent of overweight among US children and adolescents from 1971 to 2000
Int J Obes Relat Metab Disord
(2004)- et al.
Obesity evaluation and treatment: Expert Committee recommendations. The Maternal and Child Health Bureau, Health Resources and Services Administration and the Department of Health and Human Services
Pediatrics
(1998) - et al.
Prevalence of a metabolic syndrome phenotype in adolescents: findings from the third National Health and Nutrition Examination Survey, 1988-1994
Arch Pediatr Adolesc Med
(2003) - et al.
Prevention of pediatric overweight and obesity
Pediatrics
(2003)
Cited by (122)
Association of Adolescents' Body Mass Index Classification With Preventive Clinical Care Receipt
2023, Journal of Adolescent HealthFatty Liver Disease
2023, MacSween's Pathology of the Liver, Eighth EditionPediatric Nonalcoholic Fatty Liver Disease
2021, Pediatric Clinics of North AmericaCitation Excerpt :In those with advanced liver disease, portal hypertension, and its sequalae, liver transplantation has been described, and now NASH is increasingly recognized as one of the leading indications for liver transplantation in adults.15 As our awareness of this entity has heightened over the years, our frequency of screening to identify these patients has improved compared to that in prior decades.16,17 Screening is still done based on biochemical parameters, specifically the ALT.
Defining paediatric metabolic (dysfunction)-associated fatty liver disease: an international expert consensus statement
2021, The Lancet Gastroenterology and HepatologyCitation Excerpt :The new criteria provide paediatricians with a conceptual framework that can help increase disease awareness and allow providers to direct scarce resources to individuals at increased hepatic and cardiometabolic risk. A study showed that the majority of children who were overweight in general and subspecialty outpatient clinics in the USA were not diagnosed with or did not receive relevant and recommended evaluations and interventions for obesity comorbidities, including fatty liver disease.135 In this context, in all children with obesity, type 2 diabetes, evidence of metabolic dysfunction (eg, insulin resistance, dyslipidaemia, and high blood pressure), chronic abnormal liver enzyme concentrations, sleep apnoea, polycystic ovarian syndrome, or a family history of fatty liver disease,136 we recommend active case finding for MAFLD.
Prediction of Childhood Obesity from Nationwide Health Records
2021, Journal of PediatricsNonalcoholic Liver Disease in Children and Adolescents
2018, Clinics in Liver Disease